MCID: HMS001
MIFTS: 44

Hemosiderosis

Categories: Rare diseases, Metabolic diseases

Aliases & Classifications for Hemosiderosis

MalaCards integrated aliases for Hemosiderosis:

Name: Hemosiderosis 12 50 52 42 14 69
Iron Overload 42 69
Haemosiderosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12119
NCIt 47 C82892
SNOMED-CT 64 190849009 39011001
UMLS 69 C0019114

Summaries for Hemosiderosis

Disease Ontology : 12 An iron metabolism disease that has material basis in an accumulation of hemosiderin, an iron-storage complex, resulting in iron overload.

MalaCards based summary : Hemosiderosis, also known as iron overload, is related to sickle cell anemia and porphyria cutanea tarda. An important gene associated with Hemosiderosis is TF (Transferrin), and among its related pathways/superpathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Insulin receptor recycling. The drugs Deferasirox and Iron have been mentioned in the context of this disorder. Affiliated tissues include liver, lung and heart, and related phenotypes are hematopoietic system and liver/biliary system

Wikipedia : 72 Hemosiderosis (AmE) or haemosiderosis (BrE) is a form of iron overload disorder resulting in the... more...

Related Diseases for Hemosiderosis

Diseases related to Hemosiderosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 156)
id Related Disease Score Top Affiliating Genes
1 sickle cell anemia 28.8 EPO HFE TF TFRC
2 porphyria cutanea tarda 28.3 HAMP HFE TF TFRC
3 iron overload in africa 12.6
4 hypochromic microcytic anemia with iron overload 12.4
5 pulmonary hemosiderosis 12.4
6 anemia, hypochromic microcytic, with iron overload 2 12.3
7 anemia, hypochromic microcytic, with iron overload 1 12.3
8 genetic hyperferritinemia without iron overload 12.0
9 secondary pulmonary hemosiderosis 11.9
10 atransferrinemia 11.3
11 cerebellar ataxia 11.1
12 gracile syndrome 10.9
13 superficial siderosis 10.8
14 ovarian cyst 10.5 CP HFE
15 achilles bursitis 10.5 CP TF
16 hereditary multiple osteochondromas 10.5 HFE SLC11A2
17 distal arthrogryposis 10.5 SLC11A2 TF
18 female infertility of uterine origin 10.5 GPT TF
19 dermatoosteolysis, kirghizian type 10.4 HFE TF
20 early-onset zonular cataract 10.4 CP TF
21 mental retardation, x-linked, syndromic 15 10.4 CP TF
22 cerebral sarcoidosis 10.3 EPO TF
23 bladder sarcoma 10.2 GPT TF
24 posterior foramen magnum meningioma 10.2 TF TFRC
25 hemochromatosis 10.2
26 hepatitis 10.1
27 conjunctival vascular disease 10.1 EPO TFRC
28 pyruvate kinase deficiency 10.1 EPO HFE
29 microcephaly 8, primary, autosomal recessive 10.0 EPO GPT TF
30 methylmalonic aciduria and homocystinuria type cblg 10.0 EPO GPT TF
31 celiac disease 10.0
32 lymphedema 10.0 GPT HFE TF
33 dic in newborn 10.0 EPO HAMP
34 adult malignant mesenchymoma 10.0 EPO TF
35 thalassemia 10.0
36 nonsyndromic hereditary sensorineural hearing loss 10.0 GPT HFE
37 deficiency anemia 9.9
38 iron deficiency anemia 9.9
39 rhizomelic chondrodysplasia punctata, type 2 9.9 HAMP HFE
40 parkinson disease 14, autosomal recessive 9.9 CP FTL
41 ovarian clear cell malignant adenofibroma 9.9 HAMP HFE TF
42 cerebritis 9.9
43 glomerulonephritis 9.9
44 poems syndrome 9.9 EPO TF TFRC
45 spinocerebellar ataxia 8 9.8 CP GPT HFE TF
46 heart disease 9.8
47 thalassemia major 9.8
48 lymphoblastic lymphoma 9.8 CP GPT HFE TF
49 paroxysmal nocturnal hemoglobinuria 9.8
50 arthritis 9.8

Graphical network of the top 20 diseases related to Hemosiderosis:



Diseases related to Hemosiderosis

Symptoms & Phenotypes for Hemosiderosis

MGI Mouse Phenotypes related to Hemosiderosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.5 CP EPO HFE SLC11A2 SLC40A1 TF
2 liver/biliary system MP:0005370 9.1 CP EPO HFE SLC11A2 SLC40A1 TFRC

Drugs & Therapeutics for Hemosiderosis

Drugs for Hemosiderosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Deferasirox Approved, Investigational Phase 4,Phase 2,Phase 3 201530-41-8 5493381
2
Iron Approved Phase 4,Phase 2,Phase 3 7439-89-6 23925
3
Deferiprone Approved Phase 4,Phase 2,Phase 3 30652-11-0 2972
4
Deferoxamine Approved, Investigational Phase 4,Phase 2,Phase 3 70-51-9 2973
5
Metformin Approved Phase 4 657-24-9 14219 4091
6 Chelating Agents Phase 4,Phase 2,Phase 3
7 Iron Chelating Agents Phase 4,Phase 2,Phase 3
8 Micronutrients Phase 4,Phase 2,Phase 3
9 Trace Elements Phase 4,Phase 2,Phase 3
10 Liver Extracts Phase 4,Phase 2,Phase 3
11 Hypoglycemic Agents Phase 4
12
Cholecalciferol Approved, Nutraceutical Phase 2 67-97-0 6221 10883523 5280795
13
Ergocalciferol Approved, Nutraceutical Phase 2 50-14-6 5280793
14
Vitamin D Approved, Nutraceutical, Vet_approved Phase 2 1406-16-2
15 Epoetin alfa Phase 2 113427-24-0
16 Hematinics Phase 2
17 Bone Density Conservation Agents Phase 2
18 Calcium, Dietary Phase 2
19 Ergocalciferols Phase 2
20 Vitamins Phase 2
21 Calciferol Nutraceutical Phase 2
22 Vitamin D2 Nutraceutical Phase 2
23
Benzocaine Approved 1994-09-7, 94-09-7 2337
24 tannic acid Approved, Nutraceutical

Interventional clinical trials:

(show all 36)

id Name Status NCT ID Phase Drugs
1 Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) Completed NCT00171301 Phase 4 Deferasirox
2 Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food Completed NCT00845871 Phase 4 deferasirox:
3 Efficacy Study in Removing Excess Iron From the Heart Completed NCT00105495 Phase 4 Ferriprox (deferiprone);Desferal (deferoxamine)
4 ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox Completed NCT00466063 Phase 4 Deferasirox
5 Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia Completed NCT01546415 Phase 4 Desferasirox
6 Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload Completed NCT00654589 Phase 4 Deferasirox
7 Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload Completed NCT00481143 Phase 4 ICL670/Deferasirox
8 The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major Not yet recruiting NCT02984475 Phase 4 Metformin
9 Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload Unknown status NCT01511848 Phase 2, Phase 3 DFP (ferriprox) and deferasirox (ICL 670);DFP, DFO
10 Safety, Tolerability, and Efficacy of Deferasirox in MDS Completed NCT00469560 Phase 3 Deferasirox
11 A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis Completed NCT00171171 Phase 3 deferasirox
12 Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions Completed NCT00061750 Phase 3 ICL670;deferoxamine
13 Clinical Importance of Treating Iron Overload in Sickle Cell Disease Terminated NCT00981370 Phase 3 deferasirox
14 Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis Completed NCT00631163 Phase 2 Deferasirox (ICL670)
15 Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions Completed NCT00067080 Phase 2 ICL670, deferoxamine
16 Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload Completed NCT00600938 Phase 2 Core Study: Deferasirox;Core Study: Deferoxamine;Extension: deferoxamine to deferasirox;Extension: deferasirox to deferoxamine;Deferasirox;Deferoxamine
17 Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients Completed NCT00303329 Phase 2 Deferasirox
18 Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias Completed NCT00061763 Phase 2 Deferasirox
19 Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). Completed NCT01090323 Phase 2 ICL670
20 Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS) Completed NCT02428686 Phase 2 Epoetin beta (NeoRecormon)
21 A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity Completed NCT01044186 Phase 2 ICL670
22 The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) Not yet recruiting NCT02854722 Phase 2 Deferasirox and calcium-vitamin D3;Calcium-vitamin D3
23 Treatment of Iron Overload Requiring Chelation Therapy Withdrawn NCT01927913 Phase 2 SPD602;Deferasirox
24 Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease Completed NCT02434718 Phase 1 Aducanumab;Placebo
25 PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood Unknown status NCT00652964
26 Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox Completed NCT01394029 deferasirox
27 Pharmacogenetic Study in Patients Received Iron Chelating Agent Completed NCT01623895
28 Non-invasive Quantification of Liver Iron With MRI Completed NCT01516853
29 Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease Completed NCT02394431
30 The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage? Completed NCT02837354
31 Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content Recruiting NCT02025543
32 Red Blood Cell Transfusion Thresholds and QOL in MDS Recruiting NCT02099669
33 A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. Enrolling by invitation NCT01935661
34 Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter Enrolling by invitation NCT00481221
35 Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis Not yet recruiting NCT02985346 Early Phase 1
36 Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis Not yet recruiting NCT02664571

Search NIH Clinical Center for Hemosiderosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: hemosiderosis

Genetic Tests for Hemosiderosis

Anatomical Context for Hemosiderosis

MalaCards organs/tissues related to Hemosiderosis:

39
Liver, Lung, Heart, Bone, Bone Marrow, Kidney, Brain

Publications for Hemosiderosis

Articles related to Hemosiderosis:

(show top 50) (show all 493)
id Title Authors Year
1
Screening for hemosiderosis in patients receiving multiple red blood cell transfusions. ( 28129458 )
2017
2
Auricular Hemosiderosis in a Diabetic Patient. ( 28859747 )
2017
3
Welder's pulmonary hemosiderosis associated with systemic iron overload following exacerbation of acute adult T-cell leukemia/lymphoma. ( 28883221 )
2017
4
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin. ( 28642302 )
2017
5
Methylprednisolone pulse therapy rescued life-threatening pulmonary hemorrhage due to idiopathic pulmonary hemosiderosis. ( 28784257 )
2017
6
Idiopathic Pulmonary Hemosiderosis Mimicking Iron Deficiency Anemia: A Delayed Diagnosis? ( 28670434 )
2017
7
A Case of Idiopathic Pulmonary Hemosiderosis Presenting With Signs and Symptoms Mimicking Hemolytic Anemia. ( 27918350 )
2017
8
Corticosteroid in combination with leflunomide and mesenchymal stem cells for treatment of pediatric idiopathic pulmonary hemosiderosis. ( 28158572 )
2017
9
Renal Hemosiderosis among Iranian Transfusion Dependent I^-Thalassemia Major Patients. ( 28875008 )
2017
10
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST). ( 28296163 )
2017
11
Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis. ( 28251009 )
2017
12
Idiopathic pulmonary hemosiderosis: Hemorrhagic flare after 6 years of remission. ( 28844597 )
2017
13
Cor triatriatum sinister: a rare underlying cause of pulmonary hemosiderosis. ( 27026847 )
2016
14
Correlation between Heart, Liver and Pancreas Hemosiderosis Measured by MRI T2* among Thalassemia Major Patients from Iran. ( 26838079 )
2016
15
Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria. ( 27873177 )
2016
16
Unusual presentation: Concurrent IgA deficiency and idiopathic pulmonary hemosiderosis. ( 27120139 )
2016
17
Helicobacter pylori Associated With Pulmonary Hemosiderosis. ( 26741588 )
2016
18
Idiopathic Pulmonary Hemosiderosis With Allergic Asthma Diagnosis in a Pediatric Patient. ( 26241728 )
2015
19
Terminal ileum hemosiderosis secondary to prolonged oral iron ingestion. ( 25831064 )
2015
20
A young man with hemoptysis: Rare association of idiopathic pulmonary hemosiderosis, celiac disease and dilated cardiomyopathy. ( 25624603 )
2015
21
Quantitative susceptibility mapping in superficial hemosiderosis of the central nervous system. ( 26054638 )
2015
22
Idiopathic Pulmonary Hemosiderosis Presenting as Anemia, Failure to Thrive, and Jaundice in a Toddler. ( 26414632 )
2015
23
Association of Celiac Disease With Idiopathic Pulmonary Hemosiderosis; Lane Hamilton Syndrome. ( 26495097 )
2015
24
A Rare Cause of Reversible Renal Hemosiderosis. ( 26491580 )
2015
25
Idiopathic pulmonary hemosiderosis in adults: Review of cases reported in the latest 15 years. ( 26692115 )
2015
26
Idiopathic pulmonary hemosiderosis complicated by Down syndrome. ( 26508184 )
2015
27
A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis. ( 26289251 )
2015
28
Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis. ( 25904566 )
2015
29
Severe Respiratory Distress in a Child with Pulmonary Idiopathic Hemosiderosis Initially Presenting with Iron-Deficiency Anemia. ( 26634166 )
2015
30
Pulmonary Hemosiderosis Associated To Celiac Disease: Lane Hamilton Syndrome. ( 25944220 )
2015
31
YERSINIA PSEUDOTUBERCULOSIS, SEROGROUP O:1A, INFECTION IN TWO AMAZON PARROTS (AMAZONA AESTIVA AND AMAZONA ORATRIX) WITH HEPATIC HEMOSIDEROSIS. ( 26352966 )
2015
32
Idiopathic pulmonary hemosiderosis presenting in an adult: A case report and review of the literature. ( 26180395 )
2015
33
Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis. ( 25525543 )
2014
34
Secondary hemosiderosis on kidney biopsy in a patient with a left ventricular assist device. ( 24472821 )
2014
35
Superficial cerebral hemosiderosis in a patient treated with warfarin. ( 25556417 )
2014
36
Neonatal pulmonary hemosiderosis. ( 25389504 )
2014
37
Inverted cortico-medullary differentiation of renal hemosiderosis. ( 24434406 )
2014
38
Idiopathic pulmonary hemosiderosis - a diagnostic challenge. ( 24708654 )
2014
39
Renal hemosiderosis and rapidly progressive glomerulonephritis associated with primary hemochromatosis. ( 24588645 )
2014
40
Islet inflammation, hemosiderosis, and fibrosis in intrauterine growth-restricted and high fat-fed Sprague-Dawley rats. ( 24631026 )
2014
41
Pulmonary hemosiderosis in children with bronchopulmonary dysplasia. ( 25309768 )
2014
42
Donor hemosiderosis does not affect liver function and regeneration in the setting of living donor liver transplantation. ( 24354876 )
2014
43
Iron chelation with deferasirox for the treatment of secondary hemosiderosis in pediatric oncology patients: a single-center experience. ( 23669734 )
2013
44
Transfusional iron overload presenting as choroid plexus hemosiderosis. ( 24617189 )
2013
45
Cerebral amyloid angiopathy with asymmetric superficial hemosiderosis and transient focal neurological symptoms. ( 23983893 )
2013
46
Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. ( 23812505 )
2013
47
A case report of hemosiderosis-induced ventricular pacing exit block. ( 23907043 )
2013
48
Spondias pinnata stem bark extract lessens iron overloaded liver toxicity due to hemosiderosis in Swiss albino mice. ( 23293203 )
2013
49
Extracorporeal life support for a 5-week-old infant with idiopathic pulmonary hemosiderosis. ( 23942745 )
2013
50
Melioidosis and idiopathic pulmonary hemosiderosis: a cast-iron case. ( 25473541 )
2013

Variations for Hemosiderosis

Expression for Hemosiderosis

Search GEO for disease gene expression data for Hemosiderosis.

Pathways for Hemosiderosis

Pathways related to Hemosiderosis according to GeneCards Suite gene sharing:

(show all 11)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.01 CP FTL SLC11A2 SLC40A1 TF TFRC
2
Show member pathways
12.08 CP FTL SLC11A2 SLC40A1 TF TFRC
3 11.63 EPO TF TFRC
4
Show member pathways
11.59 CP SLC11A2 SLC40A1
5 11.44 CP EPO TF TFRC
6 11.27 FTL SLC11A2 SLC40A1 TF
7 11.18 EPO TF
8 11.01 EPO SLC11A2
9 10.7 CP FTL SLC11A2 SLC40A1 TF TFRC
10 10.43 HAMP SLC11A2 SLC40A1 TF TFRC
11 10.21 HAMP HFE

GO Terms for Hemosiderosis

Cellular components related to Hemosiderosis according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.97 CP EPO FTL HAMP TF TFRC
2 extracellular space GO:0005615 9.8 CP EPO GPT HAMP HFE TF
3 perinuclear region of cytoplasm GO:0048471 9.76 HFE SLC11A2 TF TFRC
4 cytoplasmic vesicle GO:0031410 9.73 HFE SLC11A2 TF TFRC
5 early endosome GO:0005769 9.65 HFE SLC11A2 TF
6 cell surface GO:0009986 9.62 EPO SLC11A2 TF TFRC
7 endosome membrane GO:0010008 9.58 SLC11A2 TF TFRC
8 blood microparticle GO:0072562 9.54 CP TF TFRC
9 clathrin-coated vesicle membrane GO:0030665 9.51 TF TFRC
10 recycling endosome GO:0055037 9.46 HFE SLC11A2 TF TFRC
11 basal part of cell GO:0045178 9.13 HFE SLC11A2 TF
12 HFE-transferrin receptor complex GO:1990712 8.8 HFE TF TFRC

Biological processes related to Hemosiderosis according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.89 CP HFE SLC11A2 SLC40A1 TF
2 acute-phase response GO:0006953 9.61 EPO HAMP HFE
3 transferrin transport GO:0033572 9.58 HFE TF TFRC
4 iron ion transport GO:0006826 9.56 FTL SLC11A2 SLC40A1 TF
5 liver regeneration GO:0097421 9.55 HAMP HFE
6 positive regulation of receptor-mediated endocytosis GO:0048260 9.54 HFE TF
7 response to vitamin A GO:0033189 9.52 EPO HAMP
8 copper ion transport GO:0006825 9.51 CP SLC11A2
9 response to iron ion GO:0010039 9.5 HAMP HFE SLC11A2
10 cellular response to iron ion GO:0071281 9.48 HFE TF
11 iron ion transmembrane transport GO:0034755 9.46 SLC11A2 SLC40A1
12 multicellular organismal iron ion homeostasis GO:0060586 9.46 HAMP HFE SLC11A2 SLC40A1
13 response to iron ion starvation GO:1990641 9.37 HAMP HFE
14 iron ion homeostasis GO:0055072 9.35 FTL HFE SLC11A2 SLC40A1 TF
15 cellular iron ion homeostasis GO:0006879 9.23 CP FTL HAMP HFE SLC11A2 SLC40A1

Molecular functions related to Hemosiderosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 ferric iron binding GO:0008199 9.26 FTL TF
2 transferrin receptor binding GO:1990459 9.16 HFE TF
3 iron ion transmembrane transporter activity GO:0005381 8.96 SLC11A2 SLC40A1
4 ferrous iron transmembrane transporter activity GO:0015093 8.62 SLC11A2 SLC40A1

Sources for Hemosiderosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....